>>>   Click for Diagenode’s approach to COVID-19


Diagenode 是 表观遗传学研究、生物样品制备和诊断分析完整解决方案方面的 全球领先提供商。公司已开发出 一种综合方法,可获得对表观遗传学研究的全新见解。 公司提供创新的 Bioruptor® 剪切和 IP-Star® 自动化仪器、 试剂盒和高质量抗体, 从而可简化 DNA® 甲基化、ChIP 和 ChIP-seq 工作流程。该公司的最新创新包括 独特的全自动化系统、 业界最有效的抗体、 用于测序中长片段生成的 Megaruptor 剪切系统以及表观遗传学分析服务。

在 Diagenode,我们的目标是制造具有自豪感和最高性能水平的产品。我们的表观遗传学专家团队通过从我们的客户以及我们周围的科学和医疗社区获得反馈来开发产品。我们致力于开发卓越且易于使用的产品,将表观遗传学研究和诊断引领至新的前沿。

Diagenode 专门服务于两个快速增长的市场


表观遗传学在生命科学研究中发挥着革命性的作用。Diagenode 不断创新解决方案,并提供最高质量的表观遗传学工具。

  • Bioruptor DNA 和染色质剪切

  • 自动化 - ChIP、DNA 甲基化、NGS 基因库制备

  • 经验证的 ChIP、DNA 甲基化和 NGS 基因库制备解决方案

  • 超验证的 ChIP 抗体


For more than 16 years, Diagenode Diagnostics has been designing, manufacturing and selling innovative real-time PCR kits for the detection of pathogens associated with various infections. Building on this expertise, Diagenode Diagnostics has developed strong partnerships with clinical microbiology laboratories as well as in vitro diagnostics companies around the world.

Molecular diagnostics kits

Diagenode Diagnostics offers a wide range of real-time PCR CE-IVD kits, in simplex or multiplex, for the detection of bacteria, parasites and viruses involved in STI, herpes infections, respiratory infections, meningitis and gastroenteritis.
Diagenode Diagnostics is currently focusing on Mycoplasma genitalium with a new CE-IVD marked real-time PCR kit detecting the strains resistant to macrolides (5 mutations, S-DiaMGResTM), in perfect synergy with the CE-IVD kit Mycoplasma genitalium / Trichomonas vaginalis (S-DiaMGTVTM).

All-in-one molecular diagnostics solution

The geneLEAD VIII, manufactured by PSS and distributed by Diagenode Diagnostics, is a new all-in-one molecular diagnostics platform designed with 8 independent tracks to carry out small series of tests (1,000 to 4,000 tests/year), from nucleic acid extraction to patient result in 1.5 hour.

Custom assay development service

Diagenode Diagnostics is ISO 13485 certified and also develops and manufactures customized molecular diagnostics tests, meeting the specific requirements of many major companies in the in vitro diagnostics market (e.g. product design, lyophilization, instrument compatibility, kit format, documentation, CE and FDA submission, distribution, PMS...).




The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics